Ikenaoncology
San Diego, US · 2 known investors
Find your way into Ikenaoncology
Sign up to see every warm intro you have to Ikenaoncology
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Ikenaoncology team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
ImageneBio is a clinical-stage biotechnology company developing therapeutics for patients with immunological, autoimmune, and inflammatory diseases. Its focus is on drug candidates with differentiated clinical profiles.
Investors · 2
Atlas Venturelisted by Atlas VentureCambridge · $500K – $1M
How we know: Atlas Venture's portfolio page · Not right? Tell us
OrbiMedlisted by OrbiMedNew York · $1M – $75M
How we know: OrbiMed's portfolio page · the VCSheet dataset · Not right? Tell us
Frequently asked questions
- What does Ikenaoncology do?
- ImageneBio is a clinical-stage biotechnology company developing therapeutics for patients with immunological, autoimmune, and inflammatory diseases. Its focus is on drug candidates with differentiated clinical profiles.
- Who are Ikenaoncology's investors?
- Ikenaoncology's investors include Atlas Venture, OrbiMed.
- Where is Ikenaoncology headquartered?
- Ikenaoncology is headquartered in San Diego, US.

